Aging, Geriatric Syndromes and Clonal Hematopoiesis

Recruiting

• Conditions: Geriatrics; Aged; Geriatric Syndromes; Cardiovascular Diseases
• Interventions: Other: Cognitive Assessment; Procedure: Blood draw for trauma measurements; Other: Activities of Daily Living Questionnaire; Other: Instrumental Activities of Daily Living, subscale of the OARS; Other: Karnofsky Self-reported Performance Rating Scale; Other: Number of Falls; Other: Physical Health Section, subscale of the OARS; Other: MOS Social Activity Survey; Other: Unintentional Weight Loss; Genetic: Peripheral Blood Draw; Genetic: Buccal Swab; Other: Heart Health and Smoking History from BRFSS questionnaire; Other: Gait Speed; Other: Grip Strength; Other: Height and Weight measurements; Other: Blood pressure measurement; Procedure: Optional bone marrow biopsy

• Registration Number: NCT02604563
• Lead Sponsor: Washington University School of Medicine

Brief Summary

In this study the investigators will incorporate a wide range of clinical variables associated with aging and cardiovascular disease to determine whether they are associated with mutation status independent of chronologic age. Clinically, aging can be operationalized using geriatric assessment, which entails a comprehensive multi-dimensional assessment of the health of an older adult, including measures of comorbidity, polypharmacy, functional status, cognition, depression, falls, social activities and social support. Given that aging is heterogeneous, geriatric assessment allows greater specificity for aging than chronological age alone.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2015-11-09
• Study First Submitted QC: 2015-11-12
• Study First Posted: 2015-11-13
• Study Start: 2016-03-10
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-23
• Last Update Posted: 2024-04-24
• Primary Completion: 2030-04-30
• Study Completion: 2030-04-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• At least 50 years of age.
• Able to understand written and spoken English.
• Able to understand and willing to sign an IRB-approved written informed consent document (or that of a legally authorized representative, if applicable for the trauma cohort)

Read More

Exclusion Criteria

• Inability or unwillingness to complete health questionnaire.

• History of a recent (<30 days) acute viral illness.

• Current cancer diagnosis and currently receiving chemotherapy or undergoing radiation therapy. A prior history of cancer is allowed if the participant completed therapy > 1 year prior to enrollment; participants with a prior diagnosis of cancer will be asked to sign a release of information for the research team to obtain records regarding their prior cancer treatment.

• Current use of drugs that cause DNA damage (e.g. Cytoxan, azathioprine, etc.) for the treatment of a non-malignant disease.

• Vulnerable populations (e.g. prisoners).

• Known infection with Hepatitis B or C, HTLV, or HIV.

• Additional exclusion for optional bone marrow aspirate/biopsy substudy:

  • Use of medications for anticoagulation or "blood thinning" including warfarin, low molecular weight heparins (enoxaparin, daltaparin) or direct-acting oral anticoagulants (dabigatran, rivaroxaban, apixaban, edoxaban or betrixaban)
  • allergy to lidocaine or other local anesthetics.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Arm A: Clonal hematopoiesis	Physical Health Section, subscale of the OARS	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Heart Health and Smoking History from BRFSS questionnaire	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Activities of Daily Living Questionnaire	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	MOS Social Activity Survey	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Unintentional Weight Loss	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Grip Strength	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Optional bone marrow biopsy	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Karnofsky Self-reported Performance Rating Scale	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Gait Speed	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Blood pressure measurement	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Heart Health and Smoking History from BRFSS questionnaire	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm C: No clonal hematopoiesis & no follow-up	Number of Falls	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	Peripheral Blood Draw	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	Grip Strength	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm A: Clonal hematopoiesis	Cognitive Assessment	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Instrumental Activities of Daily Living, subscale of the OARS	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Buccal Swab	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Height and Weight measurements	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Cognitive Assessment	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Instrumental Activities of Daily Living, subscale of the OARS	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Grip Strength	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Blood pressure measurement	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Number of Falls	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm A: Clonal hematopoiesis	Peripheral Blood Draw	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Karnofsky Self-reported Performance Rating Scale	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Peripheral Blood Draw	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm C: No clonal hematopoiesis & no follow-up	Karnofsky Self-reported Performance Rating Scale	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	MOS Social Activity Survey	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm B: No clonal hematopoiesis	Activities of Daily Living Questionnaire	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Physical Health Section, subscale of the OARS	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	MOS Social Activity Survey	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Unintentional Weight Loss	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Buccal Swab	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Optional bone marrow biopsy	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm C: No clonal hematopoiesis & no follow-up	Cognitive Assessment	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	Heart Health and Smoking History from BRFSS questionnaire	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	Gait Speed	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm B: No clonal hematopoiesis	Number of Falls	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Gait Speed	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm B: No clonal hematopoiesis	Height and Weight measurements	* Complete several self-administered health assessments at baseline and every 6 months until death. * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline and every 6 months until death. * Peripheral blood draw will occur at baseline and no more than every 6 months until death. * Buccal swabs will occur at baseline and repeated as necessary, but not more than every 6 months until death * May be approached about optional bone marrow biopsy
Arm C: No clonal hematopoiesis & no follow-up	Instrumental Activities of Daily Living, subscale of the OARS	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	Physical Health Section, subscale of the OARS	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	Blood pressure measurement	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm E: Trauma	Blood draw for trauma measurements	-Blood sample at the time of admission with initial bloodwork. For inpatient participants, weekly follow-up samples will be drawn with morning phlebotomy. A follow-up sample collection will occur 4-7 weeks after discharge.
Arm C: No clonal hematopoiesis & no follow-up	Activities of Daily Living Questionnaire	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	Unintentional Weight Loss	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	Buccal Swab	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up
Arm C: No clonal hematopoiesis & no follow-up	Height and Weight measurements	* Complete several self-administered health assessments at baseline with no further follow-up * Cognitive assessment, Gait Speed, grip strength, blood pressure, height, and weight will be performed by a member of the research team at baseline with no further follow-up * Peripheral blood draw will occur at baseline with no further follow-up * Buccal swabs will occur at baseline with no further follow-up

Primary Outcome Measures

Name	Time	Method
Background mutation rate in hematopoietic stem cells from older adults regardless of a prior cancer diagnosis as measured by the number and frequency of hematopoietic-specific mutations	Estimated to be 10 years	-The investigators will sequence the coding region of some or all of the genes in an individual's blood cells and compare results to their matched mouth cells to define hematopoietic-specific mutations. The number of hematopoietic-specific mutations per individual and the frequency of individuals with mutations will be measured.
Determine the natural history of mutations in older adults with clonal hematopoiesis as measured by risk to develop blood cancer/geriatric syndrome/illness/cardiovascular disease	Estimated to be 10 years	-Individuals with mutations will be followed longitudinally to monitor the fraction of hematopoietic cells with mutations, the functional consequences of mutations in their blood cells, and the risk of developing a blood cancer, geriatric syndrome, cardiovascular disease, or other illness.
Presence or absence of geriatric syndromes as measured by hematopoietic stem cell mutations	Estimated to be 10 years	-The presence or absence of geriatric syndromes will be correlated with the mutation status of individuals.
Presence or absence of cardiovascular disease as measured by hematopoietic stem call mutations	Estimated to be 10 years
Determine whether expansion of clonal hematopoiesis (CH) occurs following acute trauma	Estimated to be 10 years	-Measures change in variant allele fraction

Trial Locations

Locations (1)

Washington University School of Medicine; 🇺🇸 Saint Louis, Missouri, United States